AXS, the global advanced ticketing and live event technology company, has announced two key leadership appointments as part of its continued technology transformation and global growth. Nikhil Bobde ...

New hires underscore ticketing company's global growth strategy and focus on next-gen fan experiences By Dave Brooks AXS is bolstering its executive team with two major technology appointments. The ...

LOS ANGELES, October 16, 2025--(BUSINESS WIRE)--AXS, the trusted leader in advanced ticketing and live event technology worldwide, today announced two key leadership appointments as part of its ...

Axis Capital received a Hold rating and a $104.00 price target from Goldman Sachs analyst Robert Cox CFA today. The company’s shares closed yesterday at $97.34. Take advantage of TipRanks Premium at ...

SAN DIEGO -- AXS-12 (reboxetine), an investigational treatment for narcolepsy, reduced weekly cataplexy attacks and in some cases provided complete remission, the phase III SYMPHONY study showed. From ...

LOS ANGELES, Sept. 18, 2025 /PRNewswire/ -- Crypto.com Arena and AXS today announced a partnership with TicketOS, the premier corporate ticket management platform, to provide premium subscribers ...

A new win for the Army’s modernized fires execution software suite brings it one step closer to replacing the current Advanced Field Artillery Tactical Data System, AFATDS, and delivering the next ...

AXS Map and AARP New York Team Up to Launch Community Mapathon Series in NYC AXS Map is awarded the Community Challenge Grant for its wide-reaching generational and policy impact, particularly for the ...

The U.S. Food and Drug Administration (FDA) sent a “refusal to file” letter to Axsome Therapeutics, Inc. (NASDAQ:AXSM) on Monday regarding its AXS-14 (esreboxetine) treatment of fibromyalgia. The FDA ...

NEW YORK, June 09, 2025 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced ...

$AXS insiders have traded $AXS stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales. Here’s a ...